ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Investor Presentation - Treatment of Neurological Disorders, page-4

  1. 1,640 Posts.
    lightbulb Created with Sketch. 143
    Hard to say.. Minimal volume... There may be a surge of buyers or sellers as a result of the presentation but hasn't happened yet... The timetable is pretty much as expected imo ..

    It's still a medium to long term buy in my books.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.